Overview

THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death

Status:
Completed
Trial end date:
2019-12-13
Target enrollment:
Participant gender:
Summary
Study to investigate if the study drug ticagrelor and ASA is more effective than Placebo (inactive tablet) and ASA in preventing new stroke events
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Ticagrelor